Essential Tips and Strategies for Recent Blood-related Drug Litigations

Recording Date: November 12, 2009
Duration: 116 minutes

111209 Heparin Trasylol

Didn’t Attend?

Purchase the Teleconference
Audio Package $149

Purchase the Teleconference Audio Package (includes MP3 files and handbook on CD). To order or learn more, click here or contact Allison Emery at 484-324-2755 x205 or allison.emery@litigationconferences.com.

Attendees get the teleconference Audio Package for 50% off!

Agenda and Speakers

The Trasylol Litigation
• What is the drug, what is it used for, and the health problems associated with it
• Understanding the time-line of events–early signs of adverse effects to the studies to the recall
• A closer look at the New England Journal of Medicine Studies: the injuries found and the comparison to alternative drugs versus no drugs
• Utilizing these studies in your case and determining the kinds of expert(s) you’ll need
• Successful theories of liabilities and defenses and conversely the theories not working
• Estimating damages in light of the injuries presented, the breakdown of injuries and settlement projections
• Important statistics regarding number of cases
• Status of the MDL and its impact on your case
The Heparin Litigation
• What is the drug, what is it used for and the nature of the problems associated with the contaminated drug lots
• Analysis of the exposure to the contaminated drugs lots, the kinds of injuries varying across contaminated units
• Identifying the manufacturers and other companies facing liability
• The experts and the reports you’ll need for your case
• Client screening concerns
• Estimating damages in light of the injuries presented, the breakdown of injuries and settlement projections
• Important statistics regarding number of cases
• Status of the MDL and its impact on your case
• Should there be continued drug testing after FDA approval? The pros and cons of this proposal to all parties

Neil Overholtz, Esq., Aylstock, Witkin, Kreis & Overholtz, P.L.C., Pensacola
Janet Abaray, Esq., Burg Simpson Eldredge Hersh & Jardine, P.C., Cincinnati
David Lukcso, MD, MPH, Vice President-Medical Advisory Services, The NMAS Group, Rockville, MD